Market Cap

BioLineRx Ltd. Market Capitalization:

₪177.5 Million

ILS as of July 1, 2024

US$47.1 Million

business BioLineRx Ltd. Company Profile

BioLineRx Ltd. Main Stock Listing

TASE: BLRX

Market Capitalization History of BioLineRx Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of BioLineRx Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 ₪428.1 M 188.14%
Jan. 1, 2023 ₪148.6 M -59.18%
Jan. 1, 2022 ₪364.0 M -32.88%
Jan. 1, 2021 ₪542.3 M 5.23%
Jan. 1, 2020 ₪515.4 M -75.44%
Jan. 1, 2019 ₪2.10 B -39.07%
Jan. 1, 2018 ₪3.44 B -2.96%
Jan. 1, 2017 ₪3.55 B -9.47%
Jan. 1, 2016 ₪3.92 B -42.87%
Jan. 1, 2015 ₪6.86 B -26.47%
Jan. 1, 2014 ₪9.33 B -41.84%
Jan. 1, 2013 ₪16.05 B 14.36%
Jan. 1, 2012 ₪14.03 B -48.25%
Jan. 1, 2011 ₪27.12 B -30.48%
Jan. 1, 2010 ₪39.00 B 174.51%
Jan. 1, 2009 ₪14.21 B -52.19%
Jan. 1, 2008 ₪29.72 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

BioLineRx Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

BioLineRx Ltd. has the following listings and related stock indices.


Stock: TASE: BLRX

Stock: NASDAQ: BLRX

Stock: FSX: YP2A

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.